Results 151 to 160 of about 15,044 (185)
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory [PDF]
, 2018 et al,, Fagan, Anne M, Jerome, Gina
core +1 more source
Myoclonus-Dominant Corticobasal Degeneration. [PDF]
Mov Disord Clin Pract, 2018 Caballol N +8 more
europepmc +1 more source
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. [PDF]
, 2011 Al-Sarraj S. +20 more
core
Correction to: Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. [PDF]
Brain Communeuropepmc +1 more source
Ultrastructural differences in pretangles between Alzheimer disease and corticobasal degeneration revealed by comparative light and electron microscopy [PDF]
, 2014 core +1 more source
Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set [PDF]
, 2018 al., et, Besser, Lilah, Morris, John C.
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Neurology, 2009
Corticobasal degeneration (CBD) is a neurodegenerative disorder characterized clinically by a combination of cortical and basal ganglia signs. Pathologically, it is classified as a tauopathy. The most distinctive clinical feature is its unilateral or markedly asymmetric presentation; among parkinsonian syndromes, with rare exceptions, only Parkinson's ...
Stephen G, Reich, Stephen E, Grill
+5 more sources
Corticobasal degeneration (CBD) is a neurodegenerative disorder characterized clinically by a combination of cortical and basal ganglia signs. Pathologically, it is classified as a tauopathy. The most distinctive clinical feature is its unilateral or markedly asymmetric presentation; among parkinsonian syndromes, with rare exceptions, only Parkinson's ...
Stephen G, Reich, Stephen E, Grill
+5 more sources